Amarin

Vascepa sparkle set to light up Amarin's fourth quarter revenue
Endpoints
Tue, 01/7/20 - 10:31 am
Amarin
Vascepa
earnings
Amarin stock heads toward highest prices in more than a decade after new Vascepa FDA approval
Yahoo/Marketwatch
Sun, 12/15/19 - 11:20 pm
Amarin
Vascepa
FDA
Amarin eyes blockbuster Vascepa sales as FDA grants heart-helping label expansion
Fierce Pharma
Fri, 12/13/19 - 09:36 pm
Amarin
Vascepa
FDA
Cardiovascular
2 Top Biotech Buyout Candidates
Motley Fool
Wed, 12/11/19 - 10:38 am
M&A
Amarin
Vascepa
Aurinia Pharmaceuticals
voclosporin
4 FDA Dates Biotech Investors Should Circle in December
Motley Fool
Sun, 12/8/19 - 10:24 pm
FDA
Amgen
anti-inflammatories
ABP710
Bausch Health Companies
acne
IDP-123
Intra-Cellular Therapies
lumateperone
schizophrenia
Vascepa
Amarin
Go or no go? Vascepa’s finale and Allergan's pain relief
EP Vantage
Mon, 12/2/19 - 10:37 am
FDA
Amarin
Vascepa
Allergan
migraines
ubrogepant
Before 2019 closes, the FDA has 3 key approval decisions to make
Biopharma Dive
Wed, 11/27/19 - 12:43 pm
Allergan
ubrogepant
migraines
Amarin
Vascepa
Intra-Cellular Therapeutics
lumateperone
schizophrenia
bipolar disorder
drug approvals
FDA
Amarin for $20B? Novartis' MedCo deal drives fresh buyout rumors for Vascepa's maker
Fierce Pharma
Mon, 11/25/19 - 09:49 pm
Amarin
M&A
Novartis
Medicines Company
Gilead Sciences
Does Amarin Have a Dark Horse Suitor?
Motley Fool
Sun, 11/24/19 - 11:32 pm
Amarin
Vascepa
M&A
Gilead Sciences
Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.
Motley Fool
Wed, 11/20/19 - 10:02 am
Amarin
Vascepa
M&A
Amgen
Novartis
Pfizer
Acasti plays catch-up to Amarin’s Vascepa
EP Vantage
Wed, 11/20/19 - 09:56 am
Ascati
Amarin
Vascepa
CaPre
AHA: Amarin's Vascepa halts progression of arterial plaque in key study
Fierce Pharma
Mon, 11/18/19 - 09:54 am
Amarin
Vascepa
AHA
FDA
aterial plaque
What's next for Amarin? CEO John Thero talks Vascepa's label, pricing and future partnerships
Biopharma Dive
Sat, 11/16/19 - 10:35 pm
Amarin
Vascepa
John Thero
labeling
What's Next for Amarin's Stock?
Motley Fool
Fri, 11/15/19 - 10:41 am
Amarin
Vascepa
FDA
pharma stocks
advisory panels
FDA Advisory Committee Votes Unanimously in Favor of Expanding Amarin’s Vascepa Label
RAPS.org
Thu, 11/14/19 - 07:45 pm
FDA
advisory panel
Amarin
Vascepa
Shares of Amarin rise on favorable opinion from FDA committee
Marketwatch
Tue, 11/12/19 - 10:10 am
FDA
Amarin
Vascepa
Amarin (AMRN) Beats Earnings & Revenues Estimates in Q3
Zacks.com
Tue, 11/5/19 - 11:54 pm
Amarin
earnings
The future of Vascepa sales, and Amarin, could hinge on next week's panel
EP Vantage
Tue, 11/5/19 - 10:28 am
Amarin
Vascepa
FDA
advisory panels
M&A
J&J's Xarelto, Amarin's Vascepa are cost-effective, not budget friendly — ICER
Endpoints
Fri, 10/18/19 - 10:18 am
ICER
drug pricing
JNJ
Xarelto
Amarin
Vascepa
Why Amarin Investors Have Their Eyes on Nov. 14
Motley Fool
Sun, 10/13/19 - 11:41 pm
Amarin
Vascepa
FDA

Pages